Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report

Research output: Contribution to journalArticlepeer-review

Abstract

We report a case of isolated adrenocorticotropin deficiency caused by pembrolizumab. This condition can be fatal, but its rarity causes under-recognition. Oncologists should pay attention to adrenal insufficiency due to pembrolizumab.

Original languageEnglish
Article numbere04305
JournalClinical Case Reports
Volume9
Issue number6
DOIs
Publication statusPublished - Jun 2021

Keywords

  • adrenal insufficiency
  • fever of unknown origin
  • hypophysitis
  • immune-related adverse events
  • programmed cell death 1 protein inhibitor

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Isolated adrenocorticotropin deficiency induced by pembrolizumab for hypopharyngeal cancer: A case report'. Together they form a unique fingerprint.

Cite this